These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
121 related items for PubMed ID: 2139833
21. [Simvastatin (MK-733), a new HMG-CoA reductase inhibitor, in the treatment of hypercholesterolemia in elderly patients with atherosclerosis]. Giannini SD, de Góes JM, Dereviack BE, Machado C, Forti N, Diament J. Arq Bras Cardiol; 1990 Jun; 54(6):407-14. PubMed ID: 2288531 [Abstract] [Full Text] [Related]
22. [Therapy of hypercholesterolemia after heart transplantation with the HMG-CoA reductase inhibitor simvastatin in long-term follow-up]. Wenke K, Thiery J, Meiser B, Arndtz N, Seidel D, Reichart B. Z Kardiol; 1995 Feb; 84(2):130-6. PubMed ID: 7717016 [Abstract] [Full Text] [Related]
23. Simvastatin treatment of hypercholesterolemia in patients with insulin dependent diabetes mellitus. Sartor G, Katzman P, Eizyk E, Kalén J, Nilsson A, Ugander L, Ursing D. Int J Clin Pharmacol Ther; 1995 Jan; 33(1):3-6. PubMed ID: 7711988 [Abstract] [Full Text] [Related]
24. Correlation of non-high-density lipoprotein cholesterol and low-density lipoprotein cholesterol with apolipoprotein B during simvastatin + fenofibrate therapy in patients with combined hyperlipidemia (a subanalysis of the SAFARI trial). Grundy SM, Vega GL, Tomassini JE, Tershakovec AM. Am J Cardiol; 2009 Aug 15; 104(4):548-53. PubMed ID: 19660610 [Abstract] [Full Text] [Related]
26. [Comparative effects of policosanol and two HMG-CoA reductase inhibitors on type II hypercholesterolemia]. Prat H, Román O, Pino E. Rev Med Chil; 1999 Mar 30; 127(3):286-94. PubMed ID: 10436712 [Abstract] [Full Text] [Related]
27. [Simvastatin in the treatment of hypercholesterolemia]. Cigala O, Pancallo MT, Della Valle M, Marasco A, Malarbi AL. Clin Ter; 1991 Jun 15; 137(5):333-7. PubMed ID: 1832606 [Abstract] [Full Text] [Related]
28. Efficacy and tolerability of adding prescription omega-3 fatty acids 4 g/d to simvastatin 40 mg/d in hypertriglyceridemic patients: an 8-week, randomized, double-blind, placebo-controlled study. Davidson MH, Stein EA, Bays HE, Maki KC, Doyle RT, Shalwitz RA, Ballantyne CM, Ginsberg HN, COMBination of prescription Omega-3 with Simvastatin (COMBOS) Investigators. Clin Ther; 2007 Jul 15; 29(7):1354-67. PubMed ID: 17825687 [Abstract] [Full Text] [Related]
30. [Effects of simvastatin on plasma lipoproteins]. Alessandri C, Basili S, Maurelli M, Andreozzi P, Bracaglia D, Cordova C. Clin Ter; 1994 Jan 15; 144(1):3-9. PubMed ID: 8168349 [Abstract] [Full Text] [Related]
31. Comparison of combined statin-fibrate treatment to monotherapy in patients with mixed hyperlipidemia. Kłosiewicz-Latoszek L, Szostak WB, Grzybowska B, Białobrzeska-Paluszkiewicz J, Wiśniewska B, Stolarska I. Kardiol Pol; 2004 Jun 15; 60(6):567-77. PubMed ID: 15334157 [Abstract] [Full Text] [Related]
32. [Effects of simvastatin on plasma levels of lipids, lipoproteins and apolipoproteins in primary hypercholesterolemia]. Caruzzo C, Uslenghi E, Varbella F, Caruzzo E, Marcolongo M, Brusca A. Minerva Cardioangiol; 1989 Dec 15; 37(12):509-15. PubMed ID: 2695857 [Abstract] [Full Text] [Related]
33. [Comparison of 2 cholesterol synthesis inhibitors (simvastatin and pravastatin)]. Golay A, Lehmann T, James R, Pometta D. Schweiz Med Wochenschr; 1993 Aug 21; 123(33):1553-8. PubMed ID: 8372340 [Abstract] [Full Text] [Related]
34. [HMG-CoA reductase inhibitors in familial hypercholesterolemia. Therapy with simvastatin alone and in combination with cholestyramine in low dosage; a report of 2 years experiences]. Geisel J, Oette K, Burrichter H. Fortschr Med; 1990 Feb 10; 108(4):71-2, 75-6. PubMed ID: 2312032 [Abstract] [Full Text] [Related]
35. International multicentre comparison of cerivastatin with placebo and simvastatin for the treatment of patients with primary hypercholesterolaemia. International Cerivastatin Study Group. Betteridge DJ. Int J Clin Pract; 1999 Jun 10; 53(4):243-50. PubMed ID: 10563066 [Abstract] [Full Text] [Related]
36. Effects of bezafibrate and of 2 HMG-CoA reductase inhibitors on lipoprotein (a) level in hypercholesterolemic patients. Branchi A, Rovellini A, Fiorenza AM, Sommariva D. Int J Clin Pharmacol Ther; 1995 Jun 10; 33(6):345-50. PubMed ID: 7582386 [Abstract] [Full Text] [Related]
37. Post-prandial effects of gemfibrozil vs simvastatin in hypercholesterolemic subjects with borderline hypertriglyceridemia. Vigna GB, Donega P, Passaro A, Zanca R, Cattin L, Fonda M, Pauciullo P, Marotta G, Fellin R, Gasparrini S, Piliego T. Nutr Metab Cardiovasc Dis; 1999 Oct 10; 9(5):234-43. PubMed ID: 10656170 [Abstract] [Full Text] [Related]
38. [Efficacy and safety of simvastatin, a new cholesterol-lowering drug]. Mol MJ, Stuyt PM, Stalenhoef AF. Ned Tijdschr Geneeskd; 1989 Feb 18; 133(7):362-6. PubMed ID: 2927555 [Abstract] [Full Text] [Related]
39. Effect of simvastatin in CAPD patients with hypercholesterolemia. De Vecchi A, Scalamogna A, Paparella M, Colombini M, Rovellini A, Pini C, Castelnovo C. Adv Perit Dial; 1992 Feb 18; 8():331-3. PubMed ID: 1361817 [Abstract] [Full Text] [Related]
40. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice. Harley CR, Gandhi S, Blasetto J, Heien H, Sasane R, Nelson SP. Am J Geriatr Pharmacother; 2007 Sep 18; 5(3):185-94. PubMed ID: 17996658 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]